English
Home > Products > CAS NO 52240-08-1

China CAS NO 52240-08-1 Factory

We'll make each hard work to become excellent and excellent, and speed up our measures for standing from the rank of intercontinental top-grade and high-tech enterprises for CAS NO 52240-08-1,52240-08-1,Tepotinib intermediate,Tepotinib advance intermediate,3-(6-Oxo-1,6-dihydro-3-pyridazinyl), Welcome any inquiry to our firm. We're going to be glad to establish pleasant business interactions with you!
CAS NO 52240-08-1, Our goods are produced with the best raw materials. Every moment, we constantly improve the production programme. In order to ensure better quality and service, we have been focusing on the production process. We have now got high praise by partner. We're looking forward to establishing business relationship with you.

Related Products

Hot Products

  • Lifitegrast

    Lifitegrast

    Product Name:Lifitegrast
    Molecular Formula:C29H24Cl2N2O7S
    Molecular Weight;615.48
    CAS Registry Number;1025967-78-5
  • Glyoxylic acid

    Glyoxylic acid

    Product Name:Glyoxylic acid
    Molecular Formula:C2H2O3
    Molecular Weight:74.04
    CAS Registry Number:298-12-4
  • Fipronil

    Fipronil

    Product Name:Fipronil
    Molecular Formula:C12H4Cl2F6N4OS
    Molecular Weight;437.15
    CAS Registry Number;120068-37-3
  • 3,4-Dichloronitrobenzene

    3,4-Dichloronitrobenzene

    Product Name:3,4-Dichloronitrobenzene
    Molecular Formula:C6H3Cl2NO2
    Molecular Weight:192
    CAS Registry Number:99-54-7
  • 3,3-Dichloro-1-(4-Nitrophenyl)-2-Piperidinone

    3,3-Dichloro-1-(4-Nitrophenyl)-2-Piperidinone

    Product Name:3,3-Dichloro-1-(4-Nitrophenyl)-2-Piperidinone
    Molecular Formula:C11H10Cl2N2O3
    Molecular Weight:289.11
    CAS Registry Number:881386-01-2
  • Semaglutide

    Semaglutide

    Product Name:Semaglutide
    Molecular Formula:C187H291N45O59
    Molecular Weight;4113.57754
    CAS Registry Number;910463-68-2
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept